NICE backs new drug for preventing potentially fatal blood clots
The National Institute for Health and Care Excellence has approved the anti-clotting drug dabigatran (Pradaxa) as an option for treating and preventing deep vein thrombosis and pulmonary embolism. (Source: Nursing Times Breaking News)
Source: Nursing Times Breaking News - December 17, 2014 Category: Nursing Source Type: news
Boehringer starts patient enrolment in dabigatran Phase III trial to prevent ESUS
Boehringer Ingelheim has started patient enrolment in the RE-SPECT ESUS Phase III trial designed to evaluate the efficacy and safety of dabigatran etexilate to prevent recurrent embolic stroke of undetermined source (ESUS). (Source: Drug Development Technology)
Source: Drug Development Technology - December 17, 2014 Category: Pharmaceuticals Source Type: news
Boehringer reports data from Phase I trial of idarucizumab in moderate kidney impairment
Boehringer Ingelheim has reported positive Phase I results which showed that a five-minute infusion of the investigational specific antidote idarucizumab led to immediate, complete and sustained reversal of the anticoagulant effect of Pradaxa (dabiga… (Source: Drug Development Technology)
Source: Drug Development Technology - December 10, 2014 Category: Pharmaceuticals Source Type: news
Dabigatran for Patients With Venous ThromboembolismDabigatran for Patients With Venous Thromboembolism
This study examined the safety and efficacy of dabigatran as an anticoagulant for patients with DVT or pulmonary embolism requiring parenteral therapy. Evidence-Based Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 21, 2014 Category: Consumer Health News Tags: Internal Medicine Journal Article Source Type: news
PodMed: A Medical News Roundup From Johns Hopkins (with audio)
(MedPage Today) -- This week's topics include a Dengue vaccine, risk of non-occlusive coronary artery disease, preventing kidney stones, and bleeding with dabigatran. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - November 8, 2014 Category: Cardiology Source Type: news
